"Health News - Medicine, Diet and Fitness"

If you’re new here, you may want to subscribe to my RSS feed.Thanks for visiting!

… the realm of alternative/complementary medicine, spirituality, and metaphysics. … all the information that is available for holistic care and lifestyles. …

AMA (CSAPH) Report 12 of the Council on Scientific Affairs (A-97) Full Text
(more…)

If you’re new here, you may want to subscribe to my RSS feed.Thanks for visiting!

Drug information on prescription and over the counter medications includes drug interactions Allergies | Arthritis | Cancer | Diabetes | Digestion | Healthy

Pharmacy Services - Over the counter medication
(more…)

If you’re new here, you may want to subscribe to my RSS feed.Thanks for visiting!

From: Just Leaf (cache-mtc-ac05.proxy.aol.com -64.12.116.134) Subject: Mold Allergy? … usual sinus symptoms related to allergies. I. suspect mold spores. …

Vitamin Retailer
(more…)

Washington — Long-awaited resources to help the Food and Drug Administration more closely monitor the safety and effectiveness of the nation’s pharmaceuticals and medical devices will begin to flow as a result of a comprehensive new law signed Sept. 27 by President Bush.

The Food and Drug Administration Amendments Act of 2007 reauthorizes the Prescription Drug User Fee Act, the Medical Device User Fee Act and laws that govern the safety of children’s drugs and devices.

(more…)

Alcoholics given the drug Topamax — more commonly used to treat migraine headaches — were able to cut down their drinking as part of a treatment program but without needing detoxification, according to researchers.

The Associated Press reported Oct. 9 that researchers tracked 371 heavy drinkers for 14 weeks and found that 15 percent of those receiving Topamax had quit drinking for at least seven weeks, compared to 3 percent of patients not receiving the drug. The Topamax group also was more likely to cut back on drinking than the control group.

(more…)

A multi-million-dollar class-action lawsuit has been filed by a group of counties in Kentucky over problems associated with the powerful prescription painkiller OxyContin, Pharmaceutical News reported Oct. 7.

The lawsuit alleges that OxyContin maker Purdue Pharma committed fraud and was guilty of conspiracy, negligence and creating a public nuisance in its marketing of the drug, which was at the heart of an epidemic of prescription-drug abuse and overdose deaths in Kentucky and elsewhere in the U.S.

(more…)

Washington — Seniors who did not have prescription drug coverage before enrolling in Medicare’s drug benefit filled nearly twice as many prescriptions and cut their out-of-pocket costs nearly in half after signing up, according to a new report sponsored by drug manufacturers.

The study compared drug use and spending in the year before the benefit with use and spending in the benefit’s first year among tens of thousands of seniors who had no drug coverage before Part D began. Beneficiaries in this group filled an average of 1.7 prescriptions per month in 2005. The figure jumped to 3.3 prescriptions per month after the benefit launched in 2006, found the analysis, commissioned by the Pharmaceutical Research and Manufacturers of America.

(more…)

Oxidative stress has been identified and proven to be the root cause of more than 70 chronic degenerative diseases such as heart disease, cancer, stroke, diabetes, Alzheimer’s dementia, Parkinson’s disease, macular degeneration and other serious ailments, according to Dr Ray D. Strand, an expert on nutritional medicine.

(more…)

Here is another story on the growth of medical technology consumption and production in emerging regions. A few days ago we had a related post (Trends in Global Pharmaceutical Manufacturing). According to the McKinsey report, the rural health services sector will provide significant growth in the demand for pharmaceuticals.

(more…)

Conducting clinical trials overseas is nothing new, however, increasing access to capital and investment in emerging countries does appear to be relatively recent. Two new pieces (links at end) detail the move into China by pharmaceutical companies. I have covered this notion in a previous post.

(more…)